Cargando…

Predictive Factors in OCT Analysis for Visual Outcome in Exudative AMD

Background. Reliable predictive factors for therapy outcome may enable treating physicians to counsel their patients more efficiently concerning probability of improvement or time point of discontinuation of a certain therapy. Methods. This is a retrospective analysis of 87 patients with exudative a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gamulescu, Maria-Andreea, Panagakis, Georgios, Theek, Carmen, Helbig, Horst
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317217/ https://www.ncbi.nlm.nih.gov/pubmed/22523654 http://dx.doi.org/10.1155/2012/851648

Ejemplares similares

Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
por: Marques, João Pedro, et al.
Publicado: (2013)

Swept-Source OCT Angiographic Characteristics of Treatment-Naïve Nonexudative Macular Neovascularization in AMD Prior to Exudation
por: Shen, Mengxi, et al.
Publicado: (2021)

Automated large-scale prediction of exudative AMD progression using machine-read OCT biomarkers
por: Rudas, Akos, et al.
Publicado: (2023)

Prevalence of Subclinical CNV and Choriocapillaris Nonperfusion in Fellow Eyes of Unilateral Exudative AMD on OCT Angiography
por: Treister, Alison D., et al.
Publicado: (2018)

Predicting Visual Acuity in Patients Treated for AMD
por: Marginean, Beatrice-Andreea, et al.
Publicado: (2022)

Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment
por: Faatz, Henrik, et al.
Publicado: (2019)

Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting
por: Rübsam, Anne, et al.
Publicado: (2022)

Anti-VEGF-Therapie bei fibrovaskulärer und serös-vaskularisierter Pigmentepithelabhebung bei neovaskulärer AMD: Eine retrospektive Fünf-Jahres-Analyse
por: Barth, T., et al.
Publicado: (2020)

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
por: Holz, F G, et al.
Publicado: (2016)

Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
por: Lotery, A, et al.
Publicado: (2017)

Study protocol on prevalence of non-exudative macular neovascularisation and its contribution to prediction of exudation in fellow eyes with unilateral exudative AMD (EYE-NEON)
por: Thottarath, Sridevi, et al.
Publicado: (2023)

Detecting signs of retinal leakage in exudative AMD using Cirrus OCT versus SL SCAN-1, a novel integrated FD-OCT into a common slit lamp
por: Stehouwer, M., et al.
Publicado: (2015)

Polarisation-sensitive OCT is useful for evaluating retinal pigment epithelial lesions in patients with neovascular AMD
por: Schütze, Christopher, et al.
Publicado: (2016)

Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic
por: Borrelli, Enrico, et al.
Publicado: (2020)

Intravitreal Combination of Dexamethasone Sodium Phosphate and Bevacizumab in The Treatment of Exudative AMD
por: Vakalis, N., et al.
Publicado: (2015)

MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
por: Ménard, Catherine, et al.
Publicado: (2016)

Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study
por: Bilgic, Alper, et al.
Publicado: (2021)

Results of the treatment of patients with exudative AMD during the COVID-19 pandemic()
por: Arruabarrena, C., et al.
Publicado: (2022)

The learning curve of retinal detachment surgery
por: Radeck, Viola, et al.
Publicado: (2021)

Rhegmatogenous retinal detachment repair—does age, sex, and lens status make a difference?
por: Radeck, Viola, et al.
Publicado: (2022)

Tumor Necrosis Factor-Alpha in Peripical Tissue Exudates of Teeth with Apical Periodontitis
por: Pezelj-Ribarić, Sonja, et al.
Publicado: (2007)

Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration
por: Hariprasad, Seenu M., et al.
Publicado: (2012)

Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD
por: Farnoodian, Mitra, et al.
Publicado: (2018)

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
por: Tran, Thi Ha Chau, et al.
Publicado: (2017)

Unexplained visual loss after primary pars-plana-vitrectomy with silicone oil tamponade in fovea-sparing retinal detachment
por: Barth, T., et al.
Publicado: (2023)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

SD-OCT Biomarkers and the Current Status of Artificial Intelligence in Predicting Progression from Intermediate to Advanced AMD
por: Damian, Ioana, et al.
Publicado: (2022)

Correction to: Unexplained visual loss after primary pars-plana-vitrectomy with silicone oil tamponade in fovea-sparing retinal detachment
por: Barth, T., et al.
Publicado: (2023)

Intraretinal Exudates in Coats' Disease as Demonstrated by Spectral-Domain OCT
por: Kessner, Rivka, et al.
Publicado: (2012)

Pseudoflow with OCT Angiography in Eyes with Hard Exudates and Macular Drusen
por: Hou, Kirk K., et al.
Publicado: (2019)

Using directional OCT to analyze photoreceptor visibility over AMD-related drusen
por: Marsh-Armstrong, Brennan, et al.
Publicado: (2022)

Relationship Between Drusen Height and OCT Biomarkers of Atrophy in Non-Neovascular AMD
por: Au, Adrian, et al.
Publicado: (2022)

Choroidal Changes After Anti-VEGF Therapy in AMD Eyes With Different Types of Macular Neovascularization Using Swept-Source OCT Angiography
por: Shen, Mengxi, et al.
Publicado: (2023)

Real-World Results of Aflibercept versus Ranibizumab for the Treatment of Exudative AMD Using a Fixed Regimen
por: Providência, Joana, et al.
Publicado: (2018)

Association of OCT-Derived Drusen Measurements with AMD-Associated Genotypic SNPs in the Amish Population
por: Chavali, Venkata Ramana Murthy, et al.
Publicado: (2015)

Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
por: Freissinger, Sigrid, et al.
Publicado: (2020)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
por: Nakamura, Tomoko, et al.
Publicado: (2012)

Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
por: Wecker, Thomas, et al.
Publicado: (2017)

Quantitative Analysis of Lens Nuclear Density Using Optical Coherence Tomography (OCT) with a Liquid Optics Interface: Correlation between OCT Images and LOCS III Grading
por: Kim, You Na, et al.
Publicado: (2016)

Automated Identification and Segmentation of Ellipsoid Zone At-Risk Using Deep Learning on SD-OCT for Predicting Progression in Dry AMD
por: Kalra, Gagan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8v8hqrod8fipe8m85n0gtpam7n